ALTO NEUROSCIENCE, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.96 USD | -0.33% |
|
-7.43% | -.--% |
| May. 21 | Alto Neuroscience, Inc. Appoints Michael Hanley as Chief Operating Officer | CI |
| May. 14 | Alto Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Chart calendar Alto Neuroscience, Inc.
7cef53032863e48891b047dc9dcdbb.HT6pniP1zyCR48vnM1SxI70e5uW99Lda7UaWM7f3mvs.bw2f83ethG3WgqG4RgLHb49si6LimcZjnXTif_y20qRPDOHuE8CGWdazhg~72a6f21a9eec6f850e74e318f9e9bdb5
Upcoming events on Alto Neuroscience, Inc.
Past events on Alto Neuroscience, Inc.
| 2024-05-14 04:03 pm | Q1 2024 Earnings Release |
| 2024-05-09 06:30 pm | Society of Biological Psychiatry Meeting |
| 2024-03-21 04:05 pm | Q4 2023 Earnings Release |
| 2024-03-20 11:30 am | Stifel Virtual CNS Conference |
| 2024-03-18 02:30 pm | UBS Virtual CNS Day |
| 2024-03-11 | Jefferies Biotech on the Bay Summit |
| 2024-03-05 01:30 pm | TD Cowen Health Care Conference |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -37,8 -38,1 0.85% | -63,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -36,3 -37,6 3.46% | -64,8 |
|
Net income Million USD | Released Forecast Spread | -27,7 | -36,3 -36,9 1.73% | -61,5 |
|
EPS USD | Released Forecast Spread | -8,05 | -9,73 -4,70 -107.2% | -3,12 |
| Announcement Date | 22/11/23 | 21/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -11,8 -10,3 -14% | -14,4 -12,2 -18.28% | -16,5 | -17,4 | -15,9 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,2 -10,5 -7.31% | -13,4 -12,1 -10.52% | -14,0 | -15,1 | -17,0 | ||
|
Net income Million USD | Released Forecast Spread | -11,2 -10,1 -10.62% | -13,4 -12,0 -11.53% | -15,2 | -16,1 | -16,6 | -17,7 | -19,4 |
|
EPS USD | Released Forecast Spread | -6,70 -0,84 -702.4% | -0,76 -0,46 -64.5% | -0,67 | -0,71 | -0,67 | -0,66 | -0,72 |
| Announcement Date | 21/03/24 | 14/05/24 | - | - | - | - | - |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Alto Neuroscience, Inc.
| 2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ANRO Stock
- Calendar Alto Neuroscience, Inc.
